The Nifedipine Medication Market driven by growing prevalence of hypertension
![]() |
Nifedipine Medication Market |
Nifedipine
medication is extensively used to treat high blood pressure and chest pain
caused by angina. It belongs to a class of drugs known as calcium channel blockers
that work by relaxing blood vessels and decreasing blood pressure. Nifedipine
comes as an extended-release tablet, capsule, and film-coated tablet and is
prescribed for the treatment of hypertension, angina, and Raynaud's phenomenon.
Regular consumption of nifedipine helps control blood pressure and prevents
complications associated with uncontrolled hypertension such as heart attack
and stroke. The growing global prevalence of hypertension primarily drives the
demand for nifedipine medications. According to the World Health Organization,
approximately 1.13 billion people suffer from hypertension worldwide.
The global Nifedipine Medication Market is estimated to be valued at US$
1260.52 Bn in 2024 and is expected to exhibit a CAGR of 9.4% over the forecast
period 2024 to 2031, as highlighted in a new report published by Coherent
Market Insights.
Market key trends
Increasing healthcare expenditure- Rising healthcare costs have prompted
governments worldwide to increase healthcare spending which is helping improve
access to advanced drugs like nifedipine. Growing investment in healthcare
infrastructure and R&D of novel pharmaceuticals is fueling the nifedipine
medication market.
Expanding patient pool- Surging geriatric population coupled with the increasing
adoption of sedentary lifestyle among young adults has led to an exponential
rise in the number of patients diagnosed with hypertension. This wide patient
base offers significant growth opportunities for nifedipine medication market
players.
Favorable reimbursement policies- Reimbursement of nifedipine drugs by medical
insurers encourages hypertensive patients to better comply with their
prescription medicines and focus more on preventive healthcare. This acts as a
key driver for the nifedipine medication industry.
Porter's
Analysis
Threat of new entrants: The threat of new entrants is moderate as developing an
effective medication requires significant R&D investments and regulatory
approvals. However, opportunities exist for new generic players.
Bargaining power of buyers: The bargaining power of buyers is high due to the
presence of multiple vendors providing alternative treatment options. Buyers
can negotiate on price and demand innovative products.
Bargaining power of suppliers: The bargaining power of suppliers is moderate as
vendors rely on key raw material suppliers for production. Suppliers have some
control over pricing but substitution opportunities exist.
Threat of new substitutes: The threat of substitutes is high with continuous
developments in alternative treatment options including angiotensin II receptor
blockers and calcium channel blockers.
Competitive rivalry: Competition in the market is high among key players.
Key Takeaways
The Global
Nifedipine Medication Market Demand is expected to witness high growth.
The North American region currently dominates the market owing to rising
prevalence of cardiovascular diseases and availability of advanced treatment
options.
Regional analysis: Europe is anticipated to be the fastest growing regional
market during the forecast period supported by rising healthcare spending and
government initiatives to spread awareness about cardiovascular ailments. Asia
Pacific is also expected grow at a significant rate led by expanding patient
pool, increasing healthcare investments and improving access to treatment in
countries such as India and China.
Key players: Key players operating in the Nifedipine Medication market are AB
Volvo, Scania AB, Continental AG, Peloton Technology, and Daimler AG among
others. AB Volvo has a wide distribution network across major markets and
offers generic nifedipine formulations. Scania AB recently launched an extended-release
nifedipine tablet to cater to chronic needs of patients.
For more details on the report, Read- https://www.rapidwebwire.com/nifedipine-medication-market-trends-size-and-share-analysis/
Get
more insights on this topic: https://www.insightprobing.com/neurological-biomarkers-market-size-and-share-2/
Comments
Post a Comment